Mineralys Therapeutics, Inc. logo MLYS - Mineralys Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $43.00 DETAILS
HIGH: $56.00
LOW: $30.00
MEDIAN: $43.00
CONSENSUS: $43.00
UPSIDE: 66.09%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0.0 0 0.0 0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0
Gross Profit 0 (0.0) 0 (0.0) 0 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 221.4 24.4 24.4 31.4 38.3 37.9 44.6 54.0 39.3 30.8 23.7 22.5 11.9 12.3 7.8 6.1 5.6 6.8 6.6
SG&A Expenses 24.7 21.0 13.9 9.7 8.5 6.6 7.2 6.1 5.9 4.6 4.0 3.8 3.9 2.6 2.2 1.4 0.9 0.8 0.5
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 246.0 45.3 38.3 41.1 46.7 44.4 51.8 60.1 45.2 35.4 27.7 26.3 15.7 14.9 10.0 7.4 6.5 7.6 7.1
Operating Income
Operating Income (246.0) (45.3) (38.3) (41.1) (46.7) (44.4) (51.8) (60.1) (45.2) (35.4) (27.7) (26.3) (15.7) (14.9) (10.0) (7.4) (6.5) (7.6) (7.1)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 5.0 6.0 6.0 4.2 3.5 2.2 2.8 3.8 4.2 3.9 3.3 3.5 3.6 2.3 0.9 0.7 0 0 0
Profitability
EBITDA (241.1) (39.3) (32.2) (36.9) (43.3) (42.2) (48.9) (56.3) (41.0) (31.5) (24.3) (22.8) (12.1) (12.6) 0.9 0.7 0 0 0
EBIT (241.1) (39.3) (32.2) (36.9) (43.3) (42.2) (48.9) (56.3) (41.0) (31.5) (24.4) (22.8) (12.1) (12.6) (9.1) (6.7) (6.5) (7.6) (7.1)
Income Before Tax (241.1) (39.3) (32.2) (36.9) (43.3) (42.2) (48.9) (56.3) (41.0) (31.5) (24.4) (22.8) (12.1) (12.6) (9.1) (6.7) (6.5) (7.6) (7.1)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (241.1) (39.3) (32.2) (36.9) (43.3) (42.2) (48.9) (56.3) (41.0) (31.5) (24.4) (22.8) (12.1) (12.6) (9.1) (6.7) (6.5) (7.6) (7.1)
Per Share Data
EPS (Basic) -2.85 -0.47 -0.40 -0.52 -0.66 -0.79 -0.98 -1.13 -0.83 -0.70 -0.61 -0.57 -0.31 -0.51 -1.74 -1.29 -1.26 -1.48 -1.40
EPS (Diluted) -2.85 -0.47 -0.40 -0.52 -0.66 -0.79 -0.98 -1.13 -0.83 -0.70 -0.61 -0.57 -0.31 -0.51 -1.74 -1.29 -1.26 -1.48 -1.40
Shares Outstanding 84.7 82.8 80.5 70.6 65.5 53.2 50.0 49.8 49.4 44.9 40.1 39.9 39.8 24.8 5.2 5.2 5.1 5.1 5.1
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q1 2021 Q4
Current Assets
Cash & Cash Equivalents 138.3 112.8 172.9 217.6 101.8 165.0 114.1 97.3 67.9 90.4 49.3 86.3 101.1 138.2 87.7 49.0 0 10.6
Short-Term Investments 523.1 533.3 483.7 0 223.1 178.0 84.1 166.3 243.3 248.1 187.3 167.5 160.0 132.4 22.4 72.0 0 0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 6.4 4.8 382.2 10.4 11.5 7.2 4.1 6.9 8.3 12.5 0 8.4 4.6 2.7 0 (10.6) 0.1
Total Current Assets 665.8 652.5 661.4 599.8 335.3 354.5 205.4 267.7 318.0 346.8 249.1 265.4 269.5 275.3 112.8 121.9 0 11.1
Non-Current Assets
Property, Plant & Equipment 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 2.5 12.1 21.7 31.1 0 0 0 0
Other Non-Current Assets 2.0 0.4 0.4 0.1 0.4 0.4 0.5 0.5 0.4 0.4 0.1 0.1 0.1 0.0 1.6 0.6 0 0.0
Total Non-Current Assets 2.1 0.4 0.4 0.2 0.5 0.4 0.6 0.5 0.5 0.4 2.5 12.2 21.7 31.2 1.6 0.6 0 0.0
Total Assets 667.9 652.9 661.8 599.9 335.7 354.9 205.9 268.3 318.5 347.2 251.6 277.6 291.2 306.4 114.4 122.5 0 11.1
Current Liabilities
Account Payables 1.1 1.1 2.0 1.1 3.2 0.4 0.5 3.1 1.7 4.3 0.6 5.6 2.2 2.4 1.9 2.6 0 0.8
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 0 11.3 7.6 18.5 2.6 1.1 3.6 2.1 1.3 0.7 1.6 6.7 0.8 0.4 0.7 0.4 0 0.3
Total Current Liabilities 19.3 14.7 15.1 23.5 22.2 13.4 14.6 31.3 28.4 19.2 10.5 13.5 6.2 10.6 8.1 7.2 0 5.1
Non-Current Liabilities
Long-Term Debt 97.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 158.6 158.6 (6.1) 29.0
Total Non-Current Liabilities 97.6 0 0 0 0 0 0 0 0 0 0 0 0 0 158.6 158.6 (6.1) 29.0
Total Liabilities 116.9 14.7 15.1 23.5 22.2 13.4 14.6 31.3 28.4 19.2 10.5 13.5 6.2 10.6 166.7 165.9 (6.1) 34.0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0
Retained Earnings (737.6) (496.5) (457.2) (424.9) (388.0) (344.7) (302.5) (253.6) (197.2) (156.2) (124.7) (100.3) (77.6) (65.4) (52.8) (43.7) 0 (23.0)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 (251.6) 0 0 0 0 0 (22.9) 0
Total Stockholders' Equity 550.9 638.1 646.7 576.4 313.6 341.6 191.3 236.9 290.1 328.0 241.2 264.0 285.0 295.9 (52.3) (43.4) 6.1 (22.9)
Total Liabilities & Equity 667.9 652.9 661.8 599.9 335.7 354.9 205.9 268.3 318.5 347.2 251.6 277.6 291.2 306.4 114.4 122.5 0 11.1
Debt Metrics
Total Debt 97.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Debt (40.7) (112.8) (172.9) (217.6) (101.8) (165.0) (114.1) (97.3) (67.9) (90.4) (49.3) (86.3) (101.1) (138.2) (87.7) (49.0) 0 (10.6)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Operating Activities
Net Income (241.1) (39.3) (32.2) (36.9) (43.3) (42.2) (48.9) (56.3) (41.0) (31.5) (24.4) (22.8) (12.1) (12.6) (9.1) (6.7) (6.5) (7.6) (7.1)
Depreciation & Amortization 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 0 0
Stock-Based Compensation 7.4 6.5 5.3 5.8 4.6 3.6 3.1 3.1 0.0 2.2 1.5 1.6 1.3 0.7 0.2 0.2 0.0 0.0 0.0
Change in Working Capital 5.7 (2.1) (6.7) 4.6 10.8 (5.9) (19.7) 5.7 10.8 12.7 (4.0) 4.1 (7.5) (0.1) (0.9) (0.5) (0.0) 0.1 2.2
Other Non-Cash Items 195.4 (4.6) (4.2) (2.4) (2.2) (1.0) (1.3) (2.7) 0.0 (2.5) (2.1) (2.0) (2.0) (0.9) (0.4) 0.0 1.0 0.9 0
Operating Cash Flow (32.6) (39.5) (37.9) (28.9) (30.2) (45.5) (66.8) (50.2) (30.1) (19.1) (29.0) (19.0) (20.4) (12.8) (10.2) (7.0) (5.5) (6.6) (4.9)
Investing Activities
Capital Expenditure 0 0 (0.0) 0 0 0 0 (0.0) 0 (0.1) 0 0 0 0 0 0 0 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (310.2) (347.4) (268.5) (300.5) (117.9) (127.9) (63.9) (58.9) (127.3) (123.4) (73.1) (56.0) (56.1) (162.8) 0 (71.8) 0 0 0
Sales/Maturities of Investments 325 302.5 165 150 75 35 147.5 138.5 135 67.5 65 60 40 22.5 0 0 0 0 0
Other Investing Activities (200) 0 0 0 0 0 0 0 0 0 0 0 0 0 50 0 0 0 0
Investing Cash Flow (185.2) (44.9) (103.5) (150.5) (42.9) (92.9) 83.6 79.6 7.7 (56.0) (8.1) 4.0 (16.1) (140.3) 50 (71.8) 0 0 0
Financing Activities
Net Debt Issuance 96.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 6.6 0 0.1 (0.0) (0.0) (0.1) 0.1 0 0 0 0 0 0 0 0 0
Financing Cash Flow 243.3 24.3 96.7 295.2 9.8 189.3 0.1 (0.0) (0.2) 116.2 0.1 0.2 (0.6) 203.6 (1.1) (0.6) 117.7 12.0 0
Cash Position
Net Change in Cash 25.5 (60.1) (44.7) 115.8 (63.2) 50.9 16.8 29.4 (22.6) 41.1 (37.0) (14.8) (37.1) 50.5 38.7 (79.3) 112.2 5.4 (4.9)
Cash at Beginning 112.8 172.9 217.6 101.8 165.0 114.1 97.3 67.9 90.4 49.3 86.3 101.1 138.2 87.7 49.0 128.3 16.1 10.7 15.6
Cash at End 138.3 112.8 172.9 217.6 101.8 165.0 114.1 97.3 67.9 90.4 49.3 86.3 101.1 138.2 87.7 49.0 128.3 16.1 10.7
Free Cash Flow (32.6) (39.5) (37.9) (28.9) (30.2) (45.5) (66.8) (50.2) (30.1) (19.2) (29.0) (19.0) (20.4) (12.8) (10.2) (7.0) (5.5) (6.6) (4.9)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 (0.0) 0 (0.0) 0 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0 0
Operating Income (246.0) (45.3) (38.3) (41.1) (46.7) (44.4) (51.8) (60.1) (45.2) (35.4) (27.7) (26.3) (15.7) (14.9) (10.0) (7.4) (6.5) (7.6) (7.1)
Net Income (241.1) (39.3) (32.2) (36.9) (43.3) (42.2) (48.9) (56.3) (41.0) (31.5) (24.4) (22.8) (12.1) (12.6) (9.1) (6.7) (6.5) (7.6) (7.1)
EPS (Diluted) -2.85 -0.47 -0.40 -0.52 -0.66 -0.79 -0.98 -1.13 -0.83 -0.70 -0.61 -0.57 -0.31 -0.51 -1.74 -1.29 -1.26 -1.48 -1.40
Balance Sheet
Cash & Equivalents 138.3 112.8 172.9 217.6 101.8 165.0 114.1 97.3 67.9 90.4 49.3 86.3 101.1 138.2 87.7 49.0 0 10.6
Total Assets 667.9 652.9 661.8 599.9 335.7 354.9 205.9 268.3 318.5 347.2 251.6 277.6 291.2 306.4 114.4 122.5 0 11.1
Total Debt 97.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stockholders' Equity 550.9 638.1 646.7 576.4 313.6 341.6 191.3 236.9 290.1 328.0 241.2 264.0 285.0 295.9 (52.3) (43.4) 6.1 (22.9)
Cash Flow
Operating Cash Flow (32.6) (39.5) (37.9) (28.9) (30.2) (45.5) (66.8) (50.2) (30.1) (19.1) (29.0) (19.0) (20.4) (12.8) (10.2) (7.0) (5.5) (6.6) (4.9)
Capital Expenditure 0 0 (0.0) 0 0 0 0 (0.0) 0 (0.1) 0 0 0 0 0 0 0 0 0
Free Cash Flow (32.6) (39.5) (37.9) (28.9) (30.2) (45.5) (66.8) (50.2) (30.1) (19.2) (29.0) (19.0) (20.4) (12.8) (10.2) (7.0) (5.5) (6.6) (4.9)